CLINICAL_TRIALS
trial_result
· 2022-11-30
Clinical Trial Update: Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF. [Phase 4]
Summary
Phase 4 clinical trial evaluating efficacy of serotonergic antidepressants in bulimia nervosa guided by brain serotonin profile via PET imaging with [18F] MPPF.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Bulimia Nervosa | Phase 4 | Status: COMPLETED